Logo-bi
Spotlight
Solat Eslami, Zahra Barzgari, Negar Saliani, Nazli Saeedi, Abolfazl Barzegari*
Bioimpacts. 2012;2(4): 213-215. doi: 10.5681/bi.2012.028
PMCID: PMC3648937     PMID: 23678462     Scopus ID: 84876813887    
PDF
XML
Cited By:
Review
Sanjay Singh*
Bioimpacts. 2013;3(2): 53-65. doi: 10.5681/bi.2013.007
PMCID: PMC3713871     PMID: 23878788     Scopus ID: 84881502609    
PDF
XML
Cited By:
Editorial
Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2013;3(2): 49-51. doi: 10.5681/bi.2013.014
PMCID: PMC3713870     PMID: 23878787     Scopus ID: 84881521871    
PDF
XML
Cited By:
Original Research
Ibrahim Torktaz*, Faezeh Mohamadhashem, Abolghasem Esmaeili, Mohaddeseh Behjati, Sara Sharifzadeh
Bioimpacts. 2013;3(3): 141-144. doi: 10.5681/bi.2013.026
PMCID: PMC3786797     PMID: 24163807     Scopus ID: 84887341373    
PDF
XML
Cited By:
Original Research
Zohreh Ebrahimnezhad, Nosratollah Zarghami*, Manoutchehr Keyhani, Soumaye Amirsaadat, Abolfazl Akbarzadeh, Mohammad Rahmati, Zohreh Mohammad Taheri, Kazem Nejati-Koshki
Bioimpacts. 2013;3(2): 67-74. doi: 10.5681/bi.2013.005
PMCID: PMC3713872     PMID: 23878789     Scopus ID: 84881534495    
XML
Cited By:
Original Research
Umamaheswaran Gurusamy*, Steven Aibor Dkhar, Arun Kumar Annan Sudarsan, Katiboina Srinivasa Rao, Dharanipragada Kadambari, Chandrasekaran Adithan
Bioimpacts. 2014;4(2): 95-100. doi: 10.5681/bi.2014.016
PMCID: PMC4097978     PMID: 25035853     Scopus ID: 84905440942    
PDF
XML
Cited By:
Review
Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2014;4(1): 3-14. doi: 10.5681/bi.2014.011
PMCID: PMC4005281     PMID: 24790893     Scopus ID: 84898640100    
PDF
XML
Cited By:
Original Research
Yalda RahbarSaadat, Nazli Saeidi, Sepideh Zununi Vahed, Abolfazl Barzegari*, Jaleh Barar ORCID
Bioimpacts. 2015;5(1): 25-28. doi: 10.15171/bi.2015.01
PMCID: PMC4401164     PMID: 25901294     Scopus ID: 84924904679    
Review
Yadollah Omidi ORCID, Jaleh Barar* ORCID
Bioimpacts. 2014;4(2): 55-67. doi: 10.5681/bi.2014.021
PMCID: PMC4097973     PMID: 25035848     Scopus ID: 84905435584    
Review
Omid Mashinchian, Mohammad Johari-Ahar, Behnaz Ghaemi, Mohammad Rashidi, Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2014;4(3): 149-166. doi: 10.15171/bi.2014.008
PMCID: PMC4204040     PMID: 25337468     Scopus ID: 84908221773    
Editorial
Jaleh Barar* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(2): 65-69. doi: 10.15171/bi.2015.18
PMCID: PMC4492186     PMID: 26191499     Scopus ID: 84930410369    
PDF
XML
Cited By:
Perspective
Mohammad A. Rafi, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(3): 117-122. doi: 10.15171/bi.2015.22
PMCID: PMC4597158     PMID: 26457248     Scopus ID: 84944384880    
PDF
XML
Cited By:
Original Research
Jalil Pirayesh Islamian*, Mohsen Mohammadi, Behzad Baradaran, Alireza Farajollahi, Seyed Mahmoud Reza Aghamiri, Mohammad Asghari Jafarabadi, Haadi Karami, Amir Monfaredan, Dariuosh Shanehbandi
Bioimpacts. 2016;6(2): 93-98. doi: 10.15171/bi.2016.13
PMCID: PMC4981254     PMID: 27525226     Scopus ID: 84983516628    
Original Research
Babak Nami* ORCID, Armin Ghasemi-Dizgah, Akbar Vaseghi
Bioimpacts. 2016;6(2): 105-110. doi: 10.15171/bi.2016.15
PMCID: PMC4981248     PMID: 27525228     Scopus ID: 84983485978    
Original Research
Mohammad-Hossein Biglu*, Parvaneh Abotalebi, Mostafa Ghavami*
Bioimpacts. 2016;6(4): 211-217. doi: 10.15171/bi.2016.28
PMCID: PMC5326669     PMID: 28265537     Scopus ID: 85013028944    
Original Research
Masoud Asadi-Khiavi, Hossein Hamzeiy*, Sajjad Khani, Ailar Nakhlband, Jaleh Barar* ORCID
Bioimpacts. 2011;1(2): 113-119. doi: 10.5681/bi.2011.015
PMCID: PMC3648953     PMID: 23678415     Scopus ID: 84874688024    
PDF
XML
Cited By:
Editorial
Yadollah Omidi* ORCID
Bioimpacts. 2011;1(4): 199-201. doi: 10.5681/bi.2011.028
PMCID: PMC3648969     PMID: 23678428     Scopus ID: 84876726247    
PDF
XML
Cited By:
Editorial
Yadollah Omidi* ORCID
Bioimpacts. 2011;1(3): 145-147. doi: 10.5681/bi.2011.019
PMCID: PMC3648960     PMID: 23678419     Scopus ID: 84865491877    
PDF
XML
Cited By:
Editorial
Jaleh Barar* ORCID
Bioimpacts. 2012;2(1): 1-3. doi: 10.5681/bi.2012.001
PMCID: PMC3648920     PMID: 23678436     Scopus ID: 84876816540    
PDF
XML
Cited By:
Hypothesis
Mohammad Pourhassan-Moghaddam, Behrouz Farhadi, Kazem Nejati-Koshki*
Bioimpacts. 2012;2(1): 55-60. doi: 10.5681/bi.2012.007
PMCID: PMC3648915     PMID: 23678442     Scopus ID: 84876804823    
PDF
XML
Cited By:
Review
Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2012;2(3): 127-143. doi: 10.5681/bi.2012.025
PMCID: PMC3648930     PMID: 23678451     Scopus ID: 84874512835    
PDF
XML
Cited By:
Original Research
Abbas Asoudeh-Fard, Abolfazl Barzegari, Alireza Dehnad, Sepideh Bastani, Asal Golchin, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(3): 193-198. doi: 10.15171/bi.2017.22
PMCID: PMC5684510     PMID: 29159146     Scopus ID: 85032022290    
Original Research
Abolghasem Jouyban*, Djavanshir Djozan, Parastou Mohammadandashti, Aliakbar Alizadeh-Nabil, Hooshangh Ghorbanpour, Maryam Khoubnasabjafari, Mohammad Mohammadzadeh
Bioimpacts. 2017;7(2): 99-108. doi: 10.15171/bi.2017.13
PMCID: PMC5524991     PMID: 28752074     Scopus ID: 85027454703    
Review
Mohammad Reza Asgharzadeh, Jaleh Barar ORCID, Mohammad M. Pourseif, Morteza Eskandani, Mojtaba Jafari Niya, Mohammad Reza Mashayekhi, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(2): 115-133. doi: 10.15171/bi.2017.15
PMCID: PMC5524986     PMID: 28752076     Scopus ID: 85027460324    
Original Research
Muhammad Nuh Musa, Sheba Rani David* ORCID, Ihsan Nazurah Zulkipli ORCID, Abdul Hanif Mahadi, Srikumar Chakravarthi, Rajan Rajabalaya* ORCID
Bioimpacts. 2017;7(4): 227-239. doi: 10.15171/bi.2017.27
PMCID: PMC5801534     PMID: 29435430     Scopus ID: 85040995353    
Original Research
Hassan Moghtaderi, Houri Sepehri*, Ladan Delphi, Farnoosh Attari
Bioimpacts. 2018;8(3): 185-194. doi: 10.15171/bi.2018.21
PMCID: PMC6128975     PMID: 30211078     Scopus ID: 85050670106    
Review
Marziyeh Fathi, Parham Sahandi Zangabad, Sima Majidi, Jaleh Barar, Hamid Erfan-Niya, Yadollah Omidi* ORCID
Bioimpacts. 2017;7(4): 269-277. doi: 10.15171/bi.2017.32
PMCID: PMC5801539     PMID: 29435435     Scopus ID: 85041008382    
Original Research
Ayuob Aghanejad, Hiwa Babamiri, Khosro Adibkia, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2018;8(2): 117-127. doi: 10.15171/bi.2018.14
PMCID: PMC6026525     PMID: 29977833     Scopus ID: 85048082430    
Review
Sepideh Parvizpour, Jafar Razmara, Yadollah Omidi* ORCID
Bioimpacts. 2018;8(3): 223-235. doi: 10.15171/bi.2018.25
PMCID: PMC6128970     PMID: 30211082     Scopus ID: 85050689925    
Original Research
Sepideh Parvizpour, Jafar Razmara, Mohammad M. Pourseif, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(1): 45-56. doi: 10.15171/bi.2019.06
PMCID: PMC6378095     PMID: 30788259     Scopus ID: 85060470196    
Using immunoinformatic tools, a multi-epitope peptide vaccine (consisting of CD8+cytotoxic T lymphocytes epitopes, helper epitopes and adjuvant) was designed to combat the triple-negative breast cancer. The vaccine showed acceptable immunogenicity and potential to stimulate both cellular and humoral immune responses.
Editorial
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(2): 67-70. doi: 10.15171/bi.2019.09
PMCID: PMC6637218     PMID: 31334037     Scopus ID: 85067455587    
Aptamers (Aps) are short single-strand nucleic acids, which can be used as the therapeutic and targeting agent in advanced drug delivery systems. Conjugation of Aps with other entities (siRNA, toxins, drugs, DNAzyme/Ribozymes) provides advanced multifunctional nanosystems for cancer therapy.
Original Research
Mohammad Reza Asgharzadeh, Mohammad M. Pourseif, Jaleh Barar ORCID, Morteza Eskandani, Mojtaba Jafari Niya, Mohammad Reza Mashayekhi, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(3): 145-159. doi: 10.15171/bi.2019.19
PMCID: PMC6726749     PMID: 31508330     Scopus ID: 85071154393    
Increased expression of TSGA10 associated with the reduced metastasis in the MDA-MB-231 cells. TSGA10 showed interaction with HIF-1α with high affinity. TSGA10 expression is altered under the hypoxia, indicating its potential as a bio-target for cancer therapy.
Editorial
Nastran Hashemzadeh, Khosro Adibkia ORCID, Jaleh Barar* ORCID
Bioimpacts. 2019;9(1): 1-3. doi: 10.15171/bi.2019.01
PMCID: PMC6378097     PMID: 30788254     Scopus ID: 85060480524    
Editorial
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Mohammad Hossein Somi* ORCID
Bioimpacts. 2019;9(3): 123-127. doi: 10.15171/bi.2019.16
PMCID: PMC6726747     PMID: 31508327     Scopus ID: 85071152476    
Colorectal cancer (CRC) as a malignancy shows high mortality rate worldwide because of metastasis and drug resistance. Targeted multimodal nanosystems (NSs) can be developed and used against CRC with much better clinical outcomes.
Original Research
Hadi Maleki-Kakelar ORCID, Jaber Dehghani, Abolfazl Barzegari, Jaleh Barar ORCID, Masoud Shirmohamadi, Javid Sadeghi, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(2): 65-72. doi: 10.34172/bi.2020.09
PMCID: PMC7186545     PMID: 32363150     Scopus ID: 85088607061    
Based on in vitro experiments, the anti-cancer effect of the locally isolated L. plantarum was validated through some signaling pathways, including PTEN, Bax, TLR4, and AKT genes.
Original Research
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Jaleh Barar ORCID, Hamed Farzi-Khajeh, Abolfazl Barzegari, Rahimeh Mousavi, Mohammad Hossein Somi* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(1): 27-36. doi: 10.15171/bi.2020.04
PMCID: PMC6977588     PMID: 31988854     Scopus ID: 85078959970    
The current study introduces an efficient ROS-responsive enzyme-based nanobiosystem and its biological impact in colon cancer therapy. Based on physicochemical properties, AuNPs-PEG-RNase A effectively induced apoptosis in SW-480 colon cancer cells and resulted in a significant reduction in cancer cell viability.
Editorial
Mitra Dolatkhah, Yadollah Omidi* ORCID
Bioimpacts. 2019;9(4): 195-197. doi: 10.15171/bi.2019.24
PMCID: PMC6879713     PMID: 31799155     Scopus ID: 85077126191    
Dr. Yadollah Omidi (Pharm.D., Ph.D.) is a Professor of Pharmaceutical Sciences at TUOMS Faculty of Pharmacy, working on advanced multifunctional nanobiosystems. He has worked at Cardiff University and University of Pennsylvania. He has published over 210 papers and 18 book chapters, supervised and mentored over 100 graduate/postgraduate students/researchers.
Original Research
Mitra Moeinzadeh ORCID, Babak Kheirkhah* ORCID, Kumarss Amini ORCID, Ali Pouryasin ORCID
Bioimpacts. 2020;10(4): 235-242. doi: 10.34172/bi.2020.30
PMCID: PMC7502904     PMID: 32983939     Scopus ID: 85092032467    
High prevalence of HPV- 53 and HPV-16 detected among participants with normal cytology can be considered as a tip-off development of cervical cancer among Iranian women.
Original Research
Siamak Alizadeh, Abolfazl Barzegari, Abolghasem Esmaeili*, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(3): 187-193. doi: 10.34172/bi.2020.23
PMCID: PMC7416006     PMID: 32793441     Scopus ID: 85089711371    
E. coli Nissle 1917 (EcN) is proposed as an appropriate light-activated vehicle for delivery of anticancer agents to the cancer cells/tissues such colorectal cancer.
Original Research
Roya Dolatkhah ORCID, Saeed Dastgiri ORCID, Amir Taher Eftekhar Sadat, Faris Farassati, Marzieh Nezamdoust, Mohammad Hossein Somi* ORCID
BioImpacts. 2021;11(1): 5-14. doi: 10.34172/bi.2021.02
PMCID: PMC7803924     PMID: 33469503     Scopus ID: 85099264583    
It has been suggested that the pattern of specific mutation including KRAS/NRAS/BRAF, are associated with different prognostic values and responses to anti-EGFR therapies.
Original Research
Amin Khodaei ORCID, Mohammad-Reza Feizi-Derakhshi* ORCID, Behzad Mozaffari-Tazehkand ORCID
BioImpacts. 2021;11(2): 87-99. doi: 10.34172/bi.2021.16
PMCID: PMC8022238     PMID: 33842279     Scopus ID: 85106634912    
In this research, cancer data are analyzed in the form of DNA in terms of nucleotide sequences. A hybrid machine learning and statistical approach was used for classification of genomic sequences.
Original Research
Nurul Azmir Amir Hashim ORCID, Sharaniza Ab-Rahim, Wan Zurinah Wan Ngah, Sheila Nathan, Nurul Syakima Ab Mutalib, Ismail Sagap, A. Rahman A. Jamal, Musalmah Mazlan* ORCID
BioImpacts. 2021;11(1): 33-43. doi: 10.34172/bi.2021.05
PMCID: PMC7803921     PMID: 33469506     Scopus ID: 85099260140    
Global Serum from metabolomics on colorectal cancer (CRC) identified 11 differential metabolites which able to identify a new set of sample with 80% of accuracy. Pathway analysis shows purine, catecholamine and amino acid metabolism were altered in CRC patients.
Original Research
Hazwani Mohd Yusof ORCID, Sharaniza Ab-Rahim, Wan Zurinah Wan Ngah, Sheila Nathan, A Rahman A Jamal, Musalmah Mazlan* ORCID
BioImpacts. 2021;11(2): 147-156. doi: 10.34172/bi.2021.22
PMCID: PMC8022234     PMID: 33842285     Scopus ID: 85106574295    
This study highlights the differential metabolite profiling in CRC cell lines corresponding to different stages.
Original Research
Ainaz Mihanfar, Bahman Yousefi, Saber Ghazizadeh Darband, Shirin Sadighparvar, Mojtaba Kaviani, Maryam Majidinia* ORCID
BioImpacts. 2021;11(4): 253-261. doi: 10.34172/bi.2021.36
PMCID: PMC8494259     PMID: 34631487     Scopus ID: 85113774001    
Treatment of SW-480 cancer cell lines with a combination of 5-FU and melatonin results in the increment in the sensitivity of cancer cells to 5-FU through downregulation of XIAP and survivin, as well as modulation of oxidative stress.
Original Research
Fatemeh Abedi Jafari ORCID, Asghar Abdoli* ORCID, Reza Pilehchian, Neda Soleimani, Seyed Masoud Hosseini
BioImpacts. 2022;12(5): 405-414. doi: 10.34172/bi.2021.25
PMCID: PMC9596882     PMID: 36381634     Scopus ID: 85140264436    
The experiment concluded that the C. novyi nontoxic might be a suitable and safe candidate, a novel therapeutic approach to encounter such hypoxic regions in the center of tumors
Original Research
Najme Dehghani ORCID, Farzaneh Tafvizi* ORCID, Parvaneh Jafari
BioImpacts. 2021;11(4): 245-252. doi: 10.34172/bi.2021.32
PMCID: PMC8494254     PMID: 34631486     Scopus ID: PMC8494254    
The supernatant of probiotic L. rhamnosus has a great potential to inhibit the proliferation of HT-29 cells and the induction of apoptosis.
Original Research
Ysrafil Ysrafil* ORCID, Indwiani Astuti ORCID
BioImpacts. 2022;12(3): 195-202. doi: 10.34172/bi.2021.22119
PMCID: PMC9124874     PMID: 35677668     Scopus ID: 85132077892    
Chitosan nanoparticle antimiRNA-324-5p could inhibit ovarian cancer proliferation by reduce endogenous miRNA-324-5p to lead restoration of MEN1 and generates repression of GLI1 expression.
Perspective
Siamak Alizadeh ORCID, Abolghasem Esmaeili, Jaleh Barar ORCID, Yadollah Omidi* ORCID
BioImpacts. 2022;12(4): 295-299. doi: 10.34172/bi.2021.22179
PMCID: PMC9376163     PMID: 35975208     Scopus ID: 85137389032    
Optogenetics approaches can provide us with outstanding tool to extend our understanding of how cells perceive, respond, and behave in meeting with complex signals, particularly in terms of cancer evasion from the anticancer immune system functions.
Original Research
Amir Shakouri ORCID, Houman Kahroba, Hamed Hamishekar, Jalal Abdolalizadeh* ORCID
BioImpacts. 2022;12(2): 115-126. doi: 10.34172/bi.2021.39
PMCID: PMC8905592     PMID: 35411300     Scopus ID: 85126459418    
In the first stage of the procedure, medical leech saliva was extracted and for encapsulating these proteins, liposome technique was applied. Continually, nano drug applied on cancer cells and expression of genes were evaluated by Real- Time PCR and western blotting.
Perspective
Sajad Khiali ORCID, Afra Rezagholizadeh ORCID, Taher Entezari-Maleki* ORCID
BioImpacts. 2022;12(3): 291-292. doi: 10.34172/bi.2022.23266
PMCID: PMC9124879     PMID: 35677665     Scopus ID: 85132071249    
In the present perspective piece, three possible mechanisms of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an oncogenic virus in the lung have been discussed.
Original Research
Javad Firouzi ORCID, Fattah Sotoodehnejadnematalahi, Alireza Shokouhifar ORCID, Mahsa Rahimi, Niloufar Sodeifi, Parisa Sahranavardfar, Masoumeh Azimi, Ehsan Janzamin, Majid Safa, Marzieh Ebrahimi* ORCID
BioImpacts. 2022;12(5): 415-429. doi: 10.34172/bi.2022.23336
PMCID: PMC9596878     PMID: 36381630     Scopus ID: 85140213651    
The effect of silibinin evaluated on self-renewal, tumorgenicity, and metastasis potential of Mammospheres derived from MCF-7, MDA-MB231 cell lines, and MDA-MB468 aggregated cells
Original Research
Laura Cabeza ORCID, Mazen M. El-Hammadi ORCID, Raul Ortiz ORCID, Maria D. Cayero-Otero, Julia Jiménez-López ORCID, Gloria Perazzoli ORCID, Lucia Martin-Banderas ORCID, Jose M. Baeyens ORCID, Consolación Melguizo* ORCID, Jose Prados ORCID
BioImpacts. 2022;12(6): 515-531. doi: 10.34172/bi.2022.23433
PMCID: PMC9809141     PMID: 36644541     Scopus ID: 85140308481    
These results suggest that our PTX-PLGA NPs could be a suitable strategy for breast cancer therapy, improving antitumor drug efficiency and reducing systemic toxicity without altering its mechanism of action.
Original Research
Nasrollah Jabbari ORCID, Maryam Feghhi, Omid Esnaashari, Hamid Soraya, Jafar Rezaie* ORCID
BioImpacts. 2022;12(6): 549-559. doi: 10.34172/bi.2022.23489
PMCID: PMC9809134     PMID: 36644548     Scopus ID: 85143387474    
Treatment of MCF-10a, MCF-7, and MDA-MD-231 cells with Gallic acid resulted in inhibition in the activity of the exosomal secretory pathway. Gallic acid can decrease the expression of genes involved in exosomes biogenesis (Alix and CD63) and secretion (Rab proteins). In addition, Gallic acid can change the expression of autophagy markers (LC3 and P62) in these cells. MVB: multivesicular body.
Original Article
Raghdah S. Bawadud ORCID, Mayson H. Alkhatib* ORCID
Bioimpacts. 2023;13(2): 145-157. doi: 10.34172/bi.2023.23515
PMCID: PMC10182446     PMID: 37193079     Scopus ID: 85152114664    
Co-delivery of NE-DTX+TQ may probably inhibit the proliferation of T47D via the induction of apoptosis and autophagy pathways and impede the migration by reducing the BCSC population and downregulating TWIST-1 expression to decrease the epithelial-to-mesenchymal transition (EMT) of breast cancer cells
Original Research
Atena Sharifi-Rad ORCID, Zeinab Amiri-Tehranizadeh, Atiye Talebi, Niknaz Nosrati, Morvarid Medalian, Mahtab Pejhan, Nazanin Hamzkanloo, Mohammad Reza Saberi, Parisa Mokaberi, Jamshidkhan Chamani* ORCID
Bioimpacts. 2023;13(1): 5-16. doi: 10.34172/bi.2022.23592
PMCID: PMC9923809     PMID: 36817002     Scopus ID: 85152114849    
The MD simulation and spectroscopic studies of the interaction of ct-DNA and propyl acridone revealed that a transition from the extended nucleic double helix towards the denatured structure.
Original Research
Behnaz Babaye Abdollahi ORCID, Marjan Ghorbani, Hamed Hamishehkar, Reza Malekzadeh, Alireza Farajollahi* ORCID
Bioimpacts. 2023;13(1): 17-29. doi: 10.34172/bi.2022.23682
PMCID: PMC9923814     PMID: 36816996     Scopus ID: 85152117585    
This study shows the positive effect of synthesized Trastuzumab loaded PEG-Fe3O4@Au nanoparticleson increasing the death rate of Breast cancer cells during megavoltage radiation therapy.
Review
Leila Rostamizadeh ORCID, Ommoleila Molavi* ORCID, Mohsen Rashid, Fatemeh Ramazani, Behzad Baradaran, Afsaneh Lavasanaifar, Raymond Lai
BioImpacts. 2022;12(3): 261-290. doi: 10.34172/bi.2022.23896
PMCID: PMC9124882     PMID: 35677663     Scopus ID: 85132074584    
In this paper, we will review the application of the four most widely studied TLR agonists including agonists of TLR3, 4, 7, and 9 in cancer immunotherapy.
Original Article
Samaneh Tokhanbigli ORCID, Helia Alavifard ORCID, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali, Kaveh Baghaei* ORCID
Bioimpacts. 2023;13(4): 333-346. doi: 10.34172/bi.2022.24209
PMCID: PMC10460770     PMID: 37645031     Scopus ID: 85154024997    
Combining LY6E loaded DC therapy with pioglitazone improved the DC therapy effect for colorectal cancer treatment. LY6E pulsed DCs excites the CD8 positive immune responses against colorectal models. Pioglitazone inhibits IL-6 axis and formation of CRC cell lines proliferation through IL-6/STAT3 by influencing the immunosuppressive feature of the tumor microenvironment.
Original Article
Mina Yousefnezhad, Soodabeh Davaran* ORCID, Mirzaagha Babazadeh, Abolfazl Akbarzadeh, Hamidreza Pazoki-Toroudi
Bioimpacts. 2023;13(3): 241-253. doi: 10.34172/bi.2023.24252
PMCID: PMC10329752     PMID: 37431480     Scopus ID: 85157052599    
Drug repurposing is an effective strategy for identifying and using approved drugs for new therapeutic purposes. We investigated co-delivery of the antitumor drugs, doxorubicin (DOX), and ezetimibe (EZ) as a cholesterol uptake-blocking drug with PCEC on prostate cancer cell line (PC3).
Editorial
Yalda Rahbar Saadat ORCID, Jaleh Barar* ORCID
BioImpacts. 2022;12(2): 87-88. doi: 10.34172/bi.2022.24253
PMCID: PMC8905586     PMID: 35411296     Scopus ID: 85127210127    
Jaleh Barar (PharmD, Ph.D.) is a Full Professor at the Faculty of Pharmacy, Tabriz University of Medical Sciences. Professor Barar is working on various aspects of pharmaceutical cell biology with particular emphasis on the development of novel drug delivery/targeting systems. Dr Barar is listed among top 1% of world scientists based on ESI ranking system.
Original Article
Mitra Torabi ORCID, Ayuob Aghanejad*, Pouria Savadi ORCID, Abolfazl Barzegari, Yadollah Omidi ORCID, Jaleh Barar* ORCID
Bioimpacts. 2023;13(3): 255-267. doi: 10.34172/bi.2023.25298
PMCID: PMC10329750     PMID: 37431477     Scopus ID: 85158830047    
Owing to their unique advantages, mesoporous silica nanoparticles (MSNPs) have attracted much attention for drug delivery and targeting. In the current study, MSNPs were fabricated, PEGylated, loaded with sunitinib, and conjugated with mucin-16 aptamer to target CA125 on ovarian cancer cells.
Original Article
Zeinab Ghazvinian ORCID, Shahrokh Abdolahi, Mohammad Ahmadvand, Amir Hossein Emami, Samad Muhammadnejad, Hamid Asadzadeh Aghdaei, Jafar Ai, Mohammad Reza Zali, Iman Seyhoun, Javad Verdi* ORCID, Kaveh Baghaei* ORCID
Bioimpacts. 2023;13(5): 383-392. doi: 10.34172/bi.2022.26386
PMCID: PMC10509737     PMID: 37736341    
Original Article
Yuri Yu. Shchegolev ORCID, Danila V. Sorokin, Alexander M. Scherbakov* ORCID, Olga E. Andreeva ORCID, Diana I. Salnikova ORCID, Ekaterina I. Mikhaevich ORCID, Margarita V. Gudkova ORCID, Mikhail A. Krasil’nikov ORCID
Bioimpacts. 2023;13(4): 313-321. doi: 10.34172/bi.2023.27490
PMCID: PMC10460766     PMID: 37645026     Scopus ID: 85168127787    
Prolonged cell treatment with mTOR inhibitor rapamycin leads to the development of resistance. Exosomes of resistant cells induce the resistance to rapamycin in the parent MCF-7cells. Exosome-induced resistance reproduces the changes revealed in the rapamycin-resistant cells, including the activation of ERK/AP-1.
Review
Katelyn R. Einloth ORCID, Scott Gayfield, Thomas McMaster, Alexander Didier, Lance Dworkin, Justin Fortune Creeden* ORCID
Bioimpacts. 2023;13(6): 439-455. doi: 10.34172/bi.2023.27521
PMCID: PMC10676524     PMID: 38022382    
Original Article
Nazila Jalilzadeh ORCID, Neda Barzgar Barough, Mehrdad Karami, Amir Baghbanzadeh, Kobra Velaei* ORCID
Bioimpacts. 2024;14(3): 27591. doi: 10.34172/bi.2023.27591
PMCID: PMC11199934     PMID: 38938757    
PDF
XML
Cited By:
Original Article
Havva Afshari ORCID, Shokoofe Noori* ORCID, Mitra Nourbakhsh, Azam Daraei, Mahsa Azami Movahed, Afshin Zarghi
Bioimpacts. 2024;14(2): 27618. doi: 10.34172/bi.2023.27618
PMCID: PMC10945297     PMID: 38505673    
PDF
XML
Cited By:
Original Article
Zeinab Mazloumi ORCID, Ali Rafat, Khadijeh Dizaji Asl, Mohammad Karimipour, Dariush Shanehbandi, Mehdi Talebi, Majid Montazer, Ali Akbar Movassaghpour, Alireza Dehnad, Raheleh Farahzadi, Hojjatollah Nozad Charoudeh* ORCID
Bioimpacts. 2024;14(4): 27640. doi: 10.34172/bi.2023.27640
PMCID: PMC11298022     PMID: 39104619    
Editorial
Mostafa Akbarzadeh-Khiavi ORCID, Azam Safary ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2024;14(1): 27696. doi: 10.34172/bi.2023.27696
PMCID: PMC10844586     PMID: 38327631    
PDF
XML
Cited By:
Original Article
Zahra Alidoost ORCID, Farnoosh Attari* ORCID, Fatemeh Saadatpour, Ehsan Arefian
Bioimpacts. 2024;14(1): 27758. doi: 10.34172/bi.2023.27758
PMCID: PMC10844590     PMID: 38327636    
PDF
XML
Cited By:
Original Article
Farzaneh Bilan ORCID, Mohammad Amini, Mohammad Amin Doustvandi, Maryam Tohidast, Amir Baghbanzadeh, Seyed Samad Hosseini ORCID, Ahad Mokhtarzadeh* ORCID, Behzad Baradaran*
Bioimpacts. 2024;14(2): 27764. doi: 10.34172/bi.2023.27764
PMCID: PMC10945301     PMID: 38505672    
PDF
XML
Cited By:
Original Article
Snehal Aditya Arvindekar* ORCID, Sanket Rathod ORCID, Prafulla Balkrishna Choudhari ORCID, Pradnya Kiran Mane ORCID, Aditya Umesh Arvindekar* ORCID, Suraj Narayan Mali ORCID, Bapu Thorat ORCID
Bioimpacts. 2024;14(5): 27783. doi: 10.34172/bi.2024.27783
PMCID: PMC11406427     PMID: 39296803    
Original Article
Hamed Zare ORCID, Hamid Bakherad* ORCID, Arman Nasr Esfahani, Mohamad Norouzi, Hossein Aghamollaei, Seyed Latif Mousavi Gargari, Fatemeh Mahmoodi, Mahdi Aliomrani, Walead Ebrahimizadeh
Bioimpacts. 2024;14(2): 27829. doi: 10.34172/bi.2023.27829
PMCID: PMC10945302     PMID: 38505675    
PDF
XML
Cited By:
Review
Sepideh Parvizpour* ORCID, Hanieh Beyrampour-Basmenj, Jafar Razmara* ORCID, Farhad Farhadi, Mohd Shahir Shamsir
Bioimpacts. 2024;14(4): 29957. doi: 10.34172/bi.2023.29957
PMCID: PMC11298019     PMID: 39104623    
Review
Maryam Samareh Salavatipour ORCID, Zahra Poursalehi, Negin Hosseini Rouzbahani, Sohaib Mohammadyar, Mohammad Vasei* ORCID
Bioimpacts. 2024;14(6): 30087. doi: 10.34172/bi.2024.30087
PDF
XML
Cited By:
Original Article
Ya-Lin Han ORCID, Li Chen, Xu-Ning Wang, Mao-Lin Xu, Rui Qin, Fang-Ming Gong, Peng Sun, Hong-Yi Liu, Zhi-Peng Teng, Zhao-Xia Li*, Guang-Hai Dai* ORCID
Bioimpacts. 2024;14(6): 30118. doi: 10.34172/bi.2024.30118